|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0700 USD | -30.00% |
|
-.--% | - |
| 17/06 | CAMP4 Therapeutics Shares Rise After JPMorgan Upgrade | MT |
| 16/06 | JPMorgan Upgrades CAMP4 Therapeutics to Overweight From Neutral, Adjusts PT to $9 From $5 | MT |
| Market Cap | 48.37L 42.27L 38.81L 36.19L 68.62L 46Cr 69.77L 4.67Cr 1.81Cr 23Cr 1.82Cr 1.78Cr 78Cr | P/E 2022 |
-8.89x | P/E 2023 | -4.74x |
|---|---|---|---|---|---|
| Enterprise Value | 21Cr 18Cr 17Cr 16Cr 30Cr 1.98TCr 30Cr 201.17Cr 78Cr 972.32Cr 78Cr 76Cr 3.35TCr | EV / Sales 2022 |
1.3x | EV / Sales 2023 | 1.22x |
| Free-Float |
100% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -30.00% |
| 3 years | 0.02 | 25.99 | |
| 5 years | 0.02 | 290.26 | |
| 10 years | 0.02 | 585.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iperti Maurizio
CEO | Chief Executive Officer | 61 | 05/03/2026 |
Jikun Kim
DFI | Director of Finance/CFO | 61 | 09/01/2023 |
Xiao Lian Zhang
DFI | Director of Finance/CFO | - | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Cynthia Paul
CHM | Chairman | 54 | 31/07/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05/24/05 | Sell | Chief Executive Officer | 8,640 | 0.5230% | ||
| 05/24/05 | Tax | Chief Financial Officer | 487 | 0.0295% | ||
| 05/24/05 | Fiscal year | Chief Executive Officer | 17,970 | 1.0878% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -30.00% | -.--% | -.--% | -99.71% | 1L | ||
| -0.77% | +5.88% | - | - | 2,13400Cr | ||
| -0.42% | -13.33% | +130.08% | +264.33% | 22TCr | ||
| +3.89% | -2.23% | -25.23% | +27.80% | 19TCr | ||
| +3.16% | -8.21% | -27.30% | +29.03% | 14TCr | ||
| -0.77% | +1.27% | +8.12% | +21.46% | 6.44TCr | ||
| +1.90% | +6.23% | +33.45% | +75.23% | 3.3TCr | ||
| +0.54% | -5.88% | +25.49% | +33.80% | 3.04TCr | ||
| +1.31% | -4.33% | -34.04% | +19.31% | 2.38TCr | ||
| +0.78% | -1.93% | -8.61% | +30.64% | 1.96TCr | ||
| Average | -2.06% | +12.57% | +11.33% | +44.65% | 28.6TCr | |
| Weighted average by Cap. | +2.31% | +3.92% | +29.23% | +101.20% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 30Cr 26Cr 24Cr 22Cr 42Cr 2.82TCr 43Cr 285.81Cr 110.77Cr 1.38TCr 111.08Cr 108.67Cr 4.76TCr | 29Cr 26Cr 24Cr 22Cr 42Cr 2.81TCr 43Cr 284.95Cr 110.43Cr 1.38TCr 110.75Cr 108.34Cr 4.75TCr |
| Net income | -2.8Cr -2.45Cr -2.25Cr -2.09Cr -3.97Cr -266.48Cr -4.04Cr -27Cr -10Cr -130.7Cr -11Cr -10Cr -450.37Cr | -3.25Cr -2.84Cr -2.61Cr -2.43Cr -4.61Cr -309.31Cr -4.69Cr -31Cr -12Cr -151.71Cr -12Cr -12Cr -522.75Cr |
| Net Debt | 13Cr 11Cr 11Cr 9.84Cr 19Cr 1.25TCr 19Cr 127.08Cr 49Cr 614.2Cr 49Cr 48Cr 2.12TCr | 20Cr 18Cr 16Cr 15Cr 29Cr 1.94TCr 29Cr 196.5Cr 76Cr 949.73Cr 76Cr 75Cr 3.27TCr |
Employees
644
- Stock Market
- Stocks
- CAMP Stock
Select your edition
All financial news and data tailored to specific country editions
















